Spontaneous loss of hepatitis C virus RNA from serum is associated with genotype 1 and younger age at exposure

Journal of Medical Virology

Volumn 83, Issue 8, 2011, Pages 1338-1344

  Rolfe, K J ^a   Curran, M D ^a   Alexander, G J M ^a   Woodall, T ^a   Andrews, N ^b   Harris, H E ^b  

^a CAMBRIDGE UNIVERSITY HOSPITALS NHS FOUNDATION TRUST   (United Kingdom)

^b PUBLIC HEALTH ENGLAND   (United Kingdom)

Author keywords

Clearance; Genotype; Hepatitis c; Serotype; Spontaneous

Indexed keywords

VIRUS ANTIBODY; VIRUS RNA;

ADULT; AGED; ARTICLE; CONTROLLED STUDY; FEMALE; GENETIC ASSOCIATION; GENOTYPE; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; PREVALENCE; REGRESSION ANALYSIS; SEROTYPING; SERUM; VIREMIA;

ADULT; AGE FACTORS; FEMALE; GENOTYPE; HEPACIVIRUS; HEPATITIS C; HUMANS; MALE; RNA, VIRAL; SERUM;

HEPATITIS C VIRUS;

EID: 79959221676     PISSN: 01466615     EISSN: 10969071     Source Type: Journal    
DOI: 10.1002/jmv.22115     Document Type: Article

References (43)

1. Alric L, Fort M, Izopet J, Vinel JP, Bureau C, Sandre K, Charlet JP, Beraud M, Abbal M, Duffaut M. 2000. Study of host- and virus-related factors associated with spontaneous hepatitis C virus clearance. Tissue Antigens 56: 154-158.
2. Amoroso P, Rapicetta M, Tosti ME, Mele A, Spada E, Buonocore S, Lettieri G, Pierri P, Chionne P, Ciccaglione AR, Sagliocca L. 1998. Correlation between virus genotype and chronicity rate in acute hepatitis C. J Hepatol 28: 939-944.
3. Bartolome J, Lopez-Alcorocho JM, Castillo I, Rodriguez-Inigo E, Quiroga JA, Palacios R, Carreno V. 2007. Ultracentrifugation of serum samples allows detection of hepatitis C virus RNA in patients with occult hepatitis C. J Virol 81: 7710-7715.
4. Carreño V. 2006. Occult hepatitis C virus infection: A new form of hepatitis C. World J Gastroenterol 12: 6922-6925.
5. Carreño V, Pardo M, Lopez-Alcorocho JM, Rodriguez-Inigo E, Bartolomé J, Castillo I. 2006. Detection of hepatitis C virus (HCV) RNA in the liver of healthy, anti-HCV antibody-positive, serum HCV RNA-negative patients with normal alanine aminotransferase levels. J Infect Dis 194: 53-60.
6. Castillo I, Pardo M, Bartolomé J. 2004. Occult hepatitis C virus infection in patients in whom the etiology of persistently abnormal results of liver-function tests is unknown. J Infect Dis 189: 7-14.
7. Forman MS, Valsamakis A. 2004. Increased sensitivity of the Roche COBAS AMPLICOR HCV test, version 2.0, using modified extraction techniques. J Mol Diagn 6: 225-230.
8. Ge D, Fellay J, Thompson AJ, Simon JS, Shianna KV, Urban TJ, Heinzen EL, Qiu P, Bertelsen AH, Muir AJ, Sulkowski M, McHutchison JG, Goldstein DB. 2009. Genetic variation in IL28B predicts hepatitis C treatment-induced viral clearance. Nature 461: 399-401.
9. Gerlach JT, Diepolder HM, Zachoval R, Gruener NH, Jung MC, Ulsenheimer A, Schraut WW, Schirren CA, Waechtler M, Backmund M, Pape GR. 2003. Acute hepatitis C: High rate of both spontaneous and treatment-induced viral clearance. Gastroenterology 125: 80-88.
10. Harris HE, Ramsay ME, Heptonstall J, Soldan K, Eldridge KP. 2000. The HCV National Register: Towards informing the natural history of hepatitis C infection in the UK. J Viral Hepat 7: 420-427.
11. Harris HE, Eldridge KP, Harbour S, Alexander G, Teo CG, Ramsay ME. 2007. Does the clinical outcome of hepatitis C infection vary with the infecting hepatitis C virus type? J Viral Hepat 14: 213-220.
12. Health Protection Agency Centre for Infections. 2009. Hepatitis C in the UK. London: Health Protection Agency Centre for Infections.
13. Hoare M, Gelson WT, Rushbrook SM, Curran MD, Woodall T, Coleman N, Davies SE, Alexander GJ. 2008. Histological changes in HCV antibody-positive, HCV RNA-negative subjects suggest persistent virus infection. Hepatology 48: 1737-1745.
14. Hwang SJ, Lee SD, Lu RH, Chu CW, Wu JC, Lai ST, Chang FY. 2001. Hepatitis C viral genotype influences the clinical outcome of patients with acute posttransfusion hepatitis C. J Med Virol 65: 505-509.
15. Knapp S, Yee LJ, Frodsham AJ, Hennig BJ, Hellier S, Zhang L, Wright M, Chiaramonte M, Graves M, Thomas HC, Hill AV, Thursz MR. 2003. Polymorphisms in interferon-induced genes and the outcome of hepatitis C virus infection: Roles of MxA, OAS-1 and PKR. Genes Immun 4: 411-419.
16. Kusumoto K, Uto H, Hayashi K, Takahama Y, Nakao H, Suruki R, Stuver SO, Ido A, Tsubouchi H. 2006. Interleukin-10 or tumor necrosis factor-alpha polymorphisms and the natural course of hepatitis C virus infection in a hyperendemic area of Japan. Cytokine 34: 24-31.
17. Lehmann M, Meyer MF, Monazahian M, Tillmann HL, Manns MP, Wedemeyer H. 2004. High rate of spontaneous clearance of acute hepatitis C virus genotype 3 infection. J Med Virol 73: 387-391.
18. Lio D, Caruso C, Di Stefano R, Colonna Romano G, Ferraro D, Scola L, Crivello A, Licata A, Valenza LM, Candore G, Craxi A, Almasio PL. 2003. IL-10 and TNF-alpha polymorphisms and the recovery from HCV infection. Hum Immunol 64: 674-680.
19. Lopez-Labrador FX, Ampurdanes S, Forns X, Castells A, Saiz JC, Costa J, Bruix J, Sanchez Tapias JM, Jimenez de Anta MT, Rodes J. 1997. Hepatitis C virus (HCV) genotypes in Spanish patients with HCV infection: Relationship between HCV genotype 1b, cirrhosis and hepatocellular carcinoma. J Hepatol 27: 959-965.
20. Mangia A, Santoro R, Piattelli M, Pazienza V, Grifa G, Iacobellis A, Andriulli A. 2004. IL-10 haplotypes as possible predictors of spontaneous clearance of HCV infection. Cytokine 25: 103-109.
21. McHutchison JG, Blatt LM, Ponnudurai R, Goodarzi K, Russell J, Conrad A. 1999. Ultracentrifugation and concentration of a large volume of serum for HCV RNA during treatment may predict sustained and relapse response in chronic HCV infection. J Med Virol 57: 351-355.
22. McKiernan SM, Hagan R, Curry M, McDonald GS, Kelly A, Nolan N, Walsh A, Hegarty J, Lawlor E, Kelleher D. 2004. Distinct MHC class I and II alleles are associated with hepatitis C viral clearance, originating from a single source. Hepatology 40: 108-114.
23. Messick K, Sanders JC, Goedert JJ, Eyster ME. 2001. Hepatitis C viral clearance and antibody reactivity patterns in persons with haemophilia and other congenital bleeding disorders. Haemophilia 7: 568-574.
24. Micallef JM, Kaldor JM, Dore GJ. 2006. Spontaneous viral clearance following acute hepatitis C infection: A systematic review of longitudinal studies. J Viral Hepat 13: 34-41.
25. Minola E, Prati D, Suter F, Maggiolo F, Caprioli F, Sonzogni A, Fraquelli M, Paggi S, Conte D. 2002. Age at infection affects the long-term outcome of transfusion-associated chronic hepatitis C. Blood 99: 4588-4591.
26. Minton EJ, Smillie D, Neal KR, Irving WL, Underwood JCE, James V, Members of the Trent Hepatitis C Virus Study Group. 1998. Association between MHC class II alleles and clearance of circulating hepatitis C virus. J Infect Dis 178: 39-44.
27. Minton EJ, Smillie D, Smith P, Shipley S, McKendrick MW, Gleeson DC, Underwood JC, Cannings C, Wilson AG. 2005. Clearance of hepatitis C virus is not associated with single nucleotide polymorphisms in the IL-1, -6, or -10 genes. Hum Immunol 66: 127-132.
28. Nousbaum JB, Pol S, Nalpas B, Landais P, Berthelot P, Brechot C. 1995. Hepatitis C virus type 1b (II) infection in France and Italy. Ann Intern Med 122: 161-168.
29. Pham TN, MacParland SA, Mulrooney PM, Cooksley H, Naoumov NV, Michalak TI. 2004. Hepatitis C virus persistence after spontaneous or treatment-induced resolution of hepatitis C. J Virol 78: 5867-5874.
30. Piasecki BA, Lewis JD, Reddy KR, Bellamy SL, Porter SB, Weinrieb RM, Stieritz DD, Chang KM. 2004. Influence of alcohol use, race, and viral coinfections on spontaneous HCV clearance in a US veteran population. Hepatology 40: 892-899.
31. Pozzato G, Kaneko S, Moretti M, Croce LS, Franzin F, Unoura M, Bercich L, Tiribelli C, Crovatto M, Santini G, et al. 1994. Different genotypes of hepatitis C virus are associated with different severity of chronic liver disease. J Med Virol 43: 291-296.
32. Radkowski M, Horban A, Gallegos-Orozco JF, Pawelczyk A, Jablonska J, Wilkinson J, Adair D, Laskus T. 2005. Evidence for viral persistence in patients who test positive for anti-hepatitis C virus antibodies and have normal alanine aminotransferase levels. J Infect Dis 191: 1730-1733.
33. Rolfe KJ, Alexander GJ, Wreghitt TG, Parmar S, Jalal H, Curran MD. 2005. A real-time Taqman method for hepatitis C virus genotyping. J Clin Virol 34: 115-121.
34. Rolfe KJ, Wreghitt TG, Alexander GJ, Curran MD. 2009. A real-time Taqman method for hepatitis C virus genotyping and methods for further subtyping of isolates. Methods Mol Biol 510: 55-71.
35. Santantonio T, Sinisi E, Guastadisegni A, Casalino C, Mazzola M, Gentile A, Leandro G, Pastore G. 2003. Natural course of acute hepatitis C: A long-term prospective study. Dig Liver Dis 35: 104-113.
36. Santantonio T, Fasano M, Sinisi E, Guastadisegni A, Casalino C, Mazzola M, Francavilla R, Pastore G. 2005. Efficacy of a 24-week course of PEG-interferon alpha-2b monotherapy in patients with acute hepatitis C after failure of spontaneous clearance. J Hepatol 42: 329-333.
37. Santantonio T, Medda E, Ferrari C, Fabris P, Cariti G, Massari M, Babudieri S, Toti M, Francavilla R, Ancarani F, Antonucci G, Scotto G, Di Marco V, Pastore G, Stroffolini T. 2006. Risk factors and outcome among a large patient cohort with community-acquired acute hepatitis C in Italy. Clin Infect Dis 43: 1154-1159.
38. Sweeting MJ, De Angelis D, Neal KR, Ramsay ME, Irving WL, Wright M, Brant L, Harris HE. 2006. Estimated progression rates in three United Kingdom hepatitis C cohorts differed according to method of recruitment. J Clin Epidemiol 59: 144-152.
39. Tanaka H, Tsukuma H, Yamano H, Okubo Y, Inoue A, Kasahara A, Hayashi N. 1998. Hepatitis C virus 1b(II) infection and development of chronic hepatitis, liver cirrhosis and hepatocellular carcinoma: A case-control study in Japan. J Epidemiol 8: 244-249.
40. Thomas DL, Astemborski J, Rai RM, Anania FA, Schaeffer M, Galai N, Nolt K, Nelson KE, Strathdee SA, Johnson L, Laeyendecker O, Boitnott J, Wilson LE, Vlahov D. 2000. The natural history of hepatitis C virus infection: Host, viral, and environmental factors. JAMA 284: 450-456.
41. Thomas DL, Thio CL, Martin MP, Qi Y, Ge D, O'Huigin C, Kidd J, Kidd K, Khakoo SI, Alexander G, Goedert JJ, Kirk GD, Donfield SM, Rosen HR, Tobler LH, Busch MP, McHutchison JG, Goldstein DB, Carrington M. 2009. Genetic variation in IL28B and spontaneous clearance of hepatitis C virus. Nature 461: 798-801.
42. Yeung LT, To T, King SM, Roberts EA. 2007. Spontaneous clearance of childhood hepatitis C virus infection. J Viral Hepat 14: 797-805.
43. Zhang M, Rosenberg PS, Brown DL, Preiss L, Konkle BA, Eyster ME, Goedert JJ. 2006. Correlates of spontaneous clearance of hepatitis C virus among people with hemophilia. Blood 107: 892-897.